神経学および神経科学ジャーナル

  • ISSN: 2171-6625
  • ジャーナル h-index: 17
  • 雑誌引用スコア: 4.43
  • ジャーナルのインパクトファクター: 3.38
インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • プロクエスト召喚
  • 科学雑誌インパクトファクター (SJIF)
  • ユーロパブ
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Diagnostic Yield of Sural Nerve Biopsy: Study from a Tertiary Care Referral Centre in India

SP Patidar, Deepika Joshi, Mishra VN, Chaurasia RN Ansari AZ and Niraj Kumar

Background: Peripheral neuropathies are a heterogeneous group of disorders with varying etiologies. A systematic approach is required for patient evaluation for cost effective diagnosis. Aims: Present study conducted at a tertiary care referral centre aimed to evaluate the clinical profile and usefulness of sural nerve biopsy.

Material and method: The study was conducted on 75 patients attending the neurology outpatient department/those admitted in the wards. All patients were subjected to a detailed clinical, neurological and necessary biochemical investigations. Those patients with an inconclusive result were subjected to a sural nerve biopsy with the results being interpreted as diagnostic, contributory or noncontributory.

Results: Out of the 75 patients enrolled 36 underwent nerve biopsy. Amongst those 18 turned out to have Hansen’s disease, 8 vasculiis, 2 CIDP, 1 diabetes and 7 patients remained undiagnosed. Overall in 15 cases the biopsy was diagnostic, in 14 cases it was contributory, while in 7 cases it was noncontributory. Nerve biopsy proved more beneficial in patients with a multiple mononeuropathy pattern (p<0.003). Overall in about 80% of patients nerve biopsy proved to be worthwhile

Conclusion: Nerve biopsy has a good diagnostic yield if done in properly selected cases. This is especially so for the asymmetrical neuropathies particularly infectious causes like leprosy and vasculitis.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません